“…50 kb, Figure B; see Table S1) which contains: i) genes encoding minimal PKS TjhA1, A2, and A3, the specific cyclases TjhC3‐C4, TjhC1, and TjhA5, and the oxygenases Tjh O2/O3, which are highly homologous to OxyA, B, C, and Oxy J‐K (first‐ring cyclase), OxyN (second‐ring cyclase), SsFL2/MtmL (the fourth‐ring cyclase), and oxygenase (OxyL and OxyE), respectively. These components are involved in the biosynthesis of either oxytetracycline or SF2575 and produce the key naphthecene intermediate (see Figure S2A), beyond which, TjhA1/A2, bearing the highest similarity with the minimal PKS, is involved in the biosynthesis of the anticancer agent mithramycin (see Figure S3); ii) tjhO4 encoding a FAD‐dependent oxidase exhibiting homology with either TcmG, for the triple hydroxylation of tetracenomycin A2 to tetracenomycin C, or the Baeyer–Villiger monooxygenase MtmOIV, the key skeleton‐modifying enzyme in mithramycin biosynthesis (see Figure S2B); iii) enzymes encoded by the tjhB9/B10 gene pair, with high homology to either KstD7/D8 or TxnB3/B4, participating in the biosynthesis of γ‐branched octose (see Figures S1 and S2C) . Additionally, the gene product of tjhO1 shows homology to the quinone‐forming monooxygenase AknX, usually involved in catalyzing the oxidization of the second ring of anthracyclines to form the anthraquinone portion of most anthracyclines .…”